MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

04 May 2021 Evaluate

Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals, has received US Food and Drug Administration (USFDA) Tentative Approval for Metronidazole Gel USP, 1%. In this regard, the company has enclosed a press release on 4th May 2021 titled ‘Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Metronidazole Gel USP, 1%’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..